Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Fluoroquinolone; topoisomerase IV and bacterial...
FXR agonist.
Triazole; 14-α demethylase inhibitor, potentia...
JAK1/2/3 inhibitor.
Polypeptide; serine protease inhibitor.
beta-Amyloid anti-oligomer and aggregation inhi...
Vitamin B1
Diterpene found in Taxus, used to synthesize ta...
Mycotoxin produced by Aspergillus; actin polyme...
Endogenous calcitonin-family peptide, involved ...
Endogenous peptide neurotransmitter, involved i...
Isoflavone found in Pueraria; 5-HT2C and GABA-A...
Recombinant protein containing Treponema pallid...
Inhibitor of ALK2, ALK3, ALK6, and AMPK.
MEK 1/2 inhibitor.
Cyclic sesquiterpene found in ginger root; pote...
Glutathione-S-transferase inhibitor.
RIP1 inhibitor.
Recombinant HIV glycoprotein antigen fragment.<...
Lipopeptide; 1,3-β-Glucan synthase inhibitor.<...